Chris Camarra
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Chris Camarra is an Independent Director at Hoth Therapeutics, Inc. starting in 2025.
Former roles include Director at 3DX Industries, Inc. from 2021 to 2024 and Executive Vice President-Communications at TC BioPharm Ltd. Education includes undergraduate studies at West Virginia University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ROCKET ONE INC. -.--% | 26-05-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ROCKET ONE INC. | Directeur/Bestuurslid | 01-05-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| 3DX INDUSTRIES, INC. | Directeur/Bestuurslid | 02-01-2024 |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research services | Public Communications Contact | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
West Virginia University
West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3DX Industries, Inc.
3DX Industries, Inc. Metal FabricationProducer Manufacturing Provides 3D metal prototyping, composite printing and precision machining services | Producer Manufacturing |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company to develop therapeutics for patients suffering from eczema | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau